1. Is Pfizer’s established drugs’ decline in China a canary in a coalmine? — Amgen biosimilar debut boosted by UnitedHealthcare coverage — Novartis CEO says FDA process could’ve been handled better — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Shiel new era

Discussion in 'Shiel' started by anonymous, Oct 12, 2017 at 8:59 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    The key to success was never to be aligned with SATAN
     
  2. anonymous

    anonymous Guest

    He will pay his dues like every character
     
  3. anonymous

    anonymous Guest

    Not only him
     
  4. anonymous

    anonymous Guest

    I Know of 5 that will join him
     
  5. anonymous

    anonymous Guest

    The site is done,but you can have some enjoyment at Quest site